Document Type : Original Article
Authors
Department of Anesthesiology and Critical Care, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Remifentanil seems to play an important role in reducing heart rate (HR) and blood pressure during electroconvulsive therapy (ECT)-induced seizures. The majority of studies have focused on the role of the intravenous administration of this drug in combination with other anesthetics; however, the effect of intranasal administration of this drug has received less attention so far. We evaluated the effect of the intranasal administration of remifentanil at different doses on ECT-induced hemodynamic changes.
Methods: This double-masked clinical trial was conducted on 80 ECT candidates divided into four groups. Before starting the ECT, the four study groups, namely REM-25, REM-50, REM-75, and control, intranasally received remifentanil at 25, 50, and 75 μg and placebo, respectively. Anesthesia induction drugs were injected 1 minute after the intranasal administration of remifentanil or placebo. Patient’s HR, diastolic blood pressure (DBP), mean arterial pressure (MAP), systolic blood pressure (SBP), and peripheral capillary oxygen saturation (SpO2) were evaluated and recorded before and 1, 5, 10, and 20 minutes after the end of convulsive movements.
Results: The patients’ SBP and MAP with 137.30±14.37 mm Hg and 100.50±11.06 mm Hg, respectively, had the highest mean in the control group as compared to three remifentanil groups 5 minutes after ECT (P value=0.042). In addition, the increase in patients’ HR in the REM-75 group, with an average of 7.70±12.54 bpm, was significantly lower than that of the REM-25 and REM-50 groups, with means of 16.15±13.80 bpm and 13.15±8.03 bpm, respectively. Moreover, the controls, with an average of 23.00±11.74 bpm, had the greatest increase in HR (P value<0.05).
Conclusion: The intranasal administration of remifentanil at different doses did not affect the length of ECT-induced seizures; however, its maximum dose (75 μg) showed the greatest decrease in patients’ SBP, MAP, and HR five minutes after administration.
Keywords
Main Subjects
- Koyama Y, Tsuzaki K, Suzuki T, Ozaki M, Saito S. Prevention of oxygen desaturation in morbidly obese patients during electroconvulsive therapy: a narrative review. J ECT. 2020;36(3):161-7. doi: 10.1097/yct.0000000000000664.
- Boere E, Birkenhäger TK, Groenland TH, van den Broek WW. Beta-blocking agents during electroconvulsive therapy: a review. Br J Anaesth. 2014;113(1):43-51. doi: 10.1093/bja/ aeu153.
- Nazemroaya B, Honarmand A, Bab Hadi Ashar M. Effects of adding dexmedetomidine to ketamine on heart rate and blood pressure changs in psychiatric patients undergoing electroconvulsive therapy. Koomesh. 2020;22(2):311-6. [Persian].
- Ali SA, Mathur N, Malhotra AK, Braga RJ. Electroconvulsive therapy and schizophrenia: a systematic review. Mol Neuropsychiatry. 2019;5(2):75-83. doi: 10.1159/000497376.
- Weerink MA, Struys M, Hannivoort LN, Barends CR, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017;56(8):893- 913. doi: 10.1007/s40262-017-0507-7.
- Cantarella G, La Camera G, Di Marco P, Grasso DC, Lanzafame B. Controlled hypotension during middle ear surgery: hemodynamic effects of remifentanil vs nitroglycerin. Ann Ital Chir. 2018;89:283-6.
- Tajabadi N, Kamali A, Alaghmand A, Jamilian H, Pazooki S, Tajerian A. The effects of remifentanil, dexmedetomidine, and metoral as adjuncts to thiopental on hemodynamic status after electroconvulsive therapy in patients with major depressive disorder: a randomized controlled clinical trial. Anesth Pain Med. 2023;13(5):e139383. doi: 10.5812/aapm-139383.
- Nasseri K, Tayebi Arasteh M, Maroufi A, Shami S. Effects of remifentanil on convulsion duration and hemodynamic responses during electroconvulsive therapy: a double-blind, randomized clinical trial. J ECT. 2009;25(3):170-3. doi: 10.1097/YCT.0b013e318199f767.
- Touitou E, Natsheh H, Boukeileh S, Awad R. Short onset and enhanced analgesia following nasal administration of noncontrolled drugs in nanovesicular systems. Pharmaceutics. 2021;13(7):978. doi: 10.3390/pharmaceutics13070978.
- Chen ST. Remifentanil: a review of its use in electroconvulsive therapy. J ECT. 2011;27(4):323-7. doi: 10.1097/ YCT.0b013e31821072d2.
- Loo C, Simpson B, MacPherson R. Augmentation strategies in electroconvulsive therapy. J ECT. 2010;26(3):202-7. doi: 10.1097/YCT.0b013e3181e48143.
- Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg. 1995;81(3):596- 602. doi: 10.1097/00000539-199509000-00031.
- Soehle M, Bochem J. Anesthesia for electroconvulsive therapy. Curr Opin Anaesthesiol. 2018;31(5):501-5. doi: 10.1097/ aco.0000000000000624.
- Andersen FA, Arsland D, Holst-Larsen H. Effects of combined methohexitone-remifentanil anaesthesia in electroconvulsive therapy. Acta Anaesthesiol Scand. 2001;45(7):830-3. doi: 10.1034/j.1399-6576.2001.045007830.x.
- Erdil F, Ozgul U, Şanli M, Kayhan G, Çolak C, Durmuş M. The effects of remifentanil on hemodynamic response attenuation after electroconvulsive therapy under sevoflurane anesthesia. J ECT. 2017;33(4):264-7. doi: 10.1097/ yct.0000000000000411.
- Yao Y, Ni J, Yang Y, Guo Y, Ye H, Chen Y. The optimum dose of intranasal remifentanil for laryngeal mask airway insertion during sevoflurane induction in children: a randomized controlled trial. Int J Clin Exp Med. 2015;8(11):21235-40.
- Kadiyala PK, Kadiyala LD. Anaesthesia for electroconvulsive therapy: An overview with an update on its role in potentiating electroconvulsive therapy. Indian J Anaesth. 2017;61(5):373- 80. doi: 10.4103/ija.IJA_132_17.
- Takekita Y, Suwa T, Sunada N, Kawashima H, Fabbri C, Kato M, et al. Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials. Eur Arch Psychiatry Clin Neurosci. 2016;266(8):703-17. doi: 10.1007/s00406-016-0670-0.
- Elefteriades JA, Hatzaras I, Tranquilli MA, Elefteriades AJ, Stout R, Shaw RK, et al. Weight lifting and rupture of silent aortic aneurysms. JAMA. 2003;290(21):2803. doi: 10.1001/ jama.290.21.2803.
- Les AS, Shadden SC, Figueroa CA, Park JM, Tedesco MM, Herfkens RJ, et al. Quantification of hemodynamics in abdominal aortic aneurysms during rest and exercise using magnetic resonance imaging and computational fluid dynamics. Ann Biomed Eng. 2010;38(4):1288-313. doi: 10.1007/s10439-010-9949-x.
- Miura K, Nakagawa H, Ohashi Y, Harada A, Taguri M, Kushiro T, et al. Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women: a metaanalysis of 16 cohort studies. Circulation. 2009;119(14):1892- 8. doi: 10.1161/circulationaha.108.823112.
)